As one of this nation's 49 National Cancer Institute (NCI)- designated Comprehensive Cancer Centers, Rutgers Cancer Institute is able to offer its patients
access to clinical trials available only at NCI - designated centers providing the most advanced treatments available.
Not exact matches
However, in very rare circumstances, Ionis Pharmaceuticals is able
to make an experimental drug that we are developing
available for patients outside of a traditional
clinical trial under an expanded
access protocol, sometimes referred
to as a treatment protocol.
We offer
access to numerous
clinical trials and new therapies that are not readily
available elsewhere.
Our
clinical trials for gynecologic cancers offer patients
access to cutting - edge therapies that may not be
available anywhere else.
We offer patients
access to the most innovative therapies and a range of
clinical trials that aren't
available at every hospital.
As one of the National Cancer Institute's designated cancer centers, Rutgers Cancer Institute of New Jersey is able
to provide
access to clinical trials not
available at other hospitals, clinics or doctor's offices, as well as
access to some of the most advanced, targeted treatments and medicines
available.
Phase 1
clinical trials give patients at University of Michigan
access to pivotal early - stage studies, connecting families
to novel treatment therapies
to patients before they are widely
available.
In addition
to the
clinical trials conducted at the Joan Karnell Cancer Center you will have
access to a number of other studies
available at the Abramson Cancer Center.
Our program offers
access to Phase I
clinical trials and First - in - children protocols
available only at a very limited number of institutions.
Certainly, they hope
to benefit personally from the new approach under study, since
clinical trials also give them
access to the latest advances
available in the nation.
Experts at the Neurosciences Institute participate in
clinical trials, giving our patients opportunities
to access new treatments and innovations before those approaches are widely
available.
Rutgers Cancer Institute provides multidisciplinary, state - of - the - art cancer care including
access to the latest medicines and most advanced treatment options
available such as
clinical trials.
Phase 1
clinical trials are used in patients for whom conventional treatment has not worked, providing
access to pivotal first - in - children, early - stage
clinical trials with novel treatments before they are widely
available.
Rutgers Cancer Institute along with its partner RWJBarnabas Health, offers patients
access to the most advanced treatment options including
clinical trials and novel therapeutics such as precision medicine, and immunotherapy — many of which are not
available at other facilities across the state.
NCI designation means we offer patients the ability
to participate in the broadest possible range of
clinical trials, with
access to potential therapies not
available at other facilities.
By participating in a
clinical trial, you may have
access to new treatments not yet
available to the market.
These
clinical trials offer local veterinarians and their patients
access to treatments that are not yet commercially
available.